What are the benefits of using Deep Inspiration Breath Hold (DIBH) technique versus free breathing in a patient with left-sided breast cancer undergoing radiotherapy?

Deep Inspiration Breath Hold (DIBH) Should Be Used for Left-Sided Breast Cancer Radiotherapy

DIBH technique is strongly recommended over free breathing for left-sided breast cancer radiotherapy as it significantly reduces cardiac radiation exposure, particularly to the heart and left anterior descending coronary artery, thereby reducing long-term cardiovascular morbidity and mortality. 1, 2

Cardiovascular Risk Reduction with DIBH

The primary benefit of DIBH is substantial reduction in cardiac radiation exposure, which directly impacts long-term cardiovascular outcomes:

• DIBH reduces mean heart dose by approximately 47-50% compared to free breathing, with mean heart doses typically reduced from 2.5-4.5 Gy down to 0.8-2.5 Gy 3, 4, 5

• Left anterior descending coronary artery (LAD) dose is reduced by 35-39% with DIBH, decreasing mean LAD dose from 14.9-26.3 Gy to 4.0-16.0 Gy 3, 4

• Left ventricle mean dose decreases by approximately 72%, from 3.9 Gy to 1.1 Gy 4

This is clinically critical because higher cardiac radiation doses are directly associated with increased risk of major coronary events, with risk beginning within the first 5 years after radiation and continuing for three decades 6. The European Society of Cardiology explicitly recommends DIBH as a heart-sparing technique that allows shielding of the heart from tangential fields without compromising clinical target volume coverage 1, 2.

Patient Selection for DIBH

At least 75% of left-sided breast cancer patients benefit from DIBH with clinically relevant cardiac dose reduction 4. The technique should be considered standard practice rather than selective 7.

Predictive Factors for Maximum Benefit:

• Parasagittal cardiac contact distance (CCD) on free breathing CT is the best predictor of cardiac exposure: the longer the CCD, the higher the cardiac dose and greater benefit from DIBH 4

• Patients with mean heart dose ≥2 Gy on free breathing plans should proceed with DIBH 5

• Both modified radical mastectomy (MRM) and breast conservation surgery (BCS) patients achieve significant cardiac dose reductions, though MRM patients may see greater absolute reductions due to higher baseline cardiac exposure 8

Patient Tolerance Considerations:

• Approximately 14% of eligible patients cannot tolerate DIBH during simulation 5

• Breath-hold stability is excellent with modern systems: mean setup variation is 0.4 mm within a single breath-hold, 1.1 mm between different breath-holds of the same beam, and 2.6 mm between different treatment days 5

Implementation Requirements

The National Comprehensive Cancer Network and European Society of Cardiology recommend respiratory control techniques including DIBH to reduce dose to heart and lung 7:

• CT-based treatment planning is mandatory to delineate cardiac structures and verify dose reduction 7, 9

• DIBH adds approximately 35 minutes to the simulation and treatment process (108 minutes total vs 73 minutes for free breathing) 8

• Active Breathing Coordinator or similar respiratory gating systems provide reproducible breath-holds 5

Lung Dose Considerations

DIBH provides mixed results for lung dose reduction:

• Some studies show no significant reduction in mean left lung dose (7.5 Gy vs 8.0 Gy, p=0.073) or lung V20 (14.6% vs 15.7%, p=0.060) 3

• Other studies demonstrate significant reductions in ipsilateral lung mean dose and V20, particularly in MRM patients requiring nodal radiation 8

• The primary indication for DIBH remains cardiac protection rather than lung sparing 1, 2

Clinical Implementation Algorithm

For all left-sided breast cancer patients undergoing radiotherapy:

1. Obtain both free breathing and DIBH planning CT scans 4, 5

2. Measure parasagittal cardiac contact distance on free breathing scan 4

3. Calculate mean heart dose on free breathing plan:

   • If ≥2 Gy: proceed with DIBH treatment 5
   • If <2 Gy: consider free breathing acceptable, though DIBH still preferred

4. Verify DIBH achieves:

   • Mean heart dose reduction ≥0.9 Gy 4
   • Mean LAD dose reduction ≥3 Gy 4
   • Mean left ventricle dose reduction ≥1.7 Gy 4

5. For patients unable to tolerate DIBH, use alternative heart-sparing techniques including prone positioning or intensity-modulated radiation therapy 7

Common Pitfalls to Avoid

• Do not assume DIBH is unnecessary for small-breasted patients: cardiac contact distance, not breast size, predicts cardiac exposure 4

• Do not skip DIBH planning CT: comparison with free breathing is essential to quantify benefit 4, 5

• Do not use DIBH without proper respiratory gating equipment: reproducibility is critical for consistent cardiac sparing 5

• For left-sided lesions, always minimize cardiac volume in tangential fields regardless of technique used 10, 11, 9